Sharma, M. R., Murciano-Goroff, Y. R., Maimon, O., Ando, Y., Rha, S. Y., Muto, M., Oh, D., Thiele, G. M., Pailden, J., Mehibel, M., Jennaro, T. S., Zhang, N., Walker, G., Subbiah, V., Hong, D. S. (2026). A phase 2 study of telisotuzumab adizutecan (ABBV-400; Temab-A) in patients with advanced solid tumors harboring
                    <i>MET</i>
                    amplification.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3157